Decreased RB phosphorylation and increased p27 expression were also observed in other NRAS‐mutant melanoma and KRAS‐mutant pancreatic carcinoma cells (Fig. S10). This evidence concerns the gene KRAS and exocrine pancreatic carcinoma.